BDBM162367 US9687479, 4 3-(5-[(5-chlorothiophen-2-yl)methyl]amino-1-[(furan-3-yl)carbonyl]-1H-pyrazol-3-yl)-1,2-dihydropyridin-2-one

SMILES Clc1ccc(CNc2cc(nn2C(=O)c2ccoc2)-c2ccc[nH]c2=O)s1

InChI Key InChIKey=ZPZMUYKLUQEYBK-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 162367   

TargetProthrombin(Human)
Verseon

US Patent
LigandPNGBDBM162367(US9687479, 4 3-(5-[(5-chlorothiophen-2-yl)methyl]a...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Human thrombin was obtained from Haematologic Technologies Inc. The chromogenic substrate S-2238 was obtained from DiaPharma. Thrombin was assayed in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetKallikrein-1(Human)
Verseon

US Patent
LigandPNGBDBM162367(US9687479, 4 3-(5-[(5-chlorothiophen-2-yl)methyl]a...)
Affinity DataIC50: 5.50E+4nMpH: 7.5 T: 2°CAssay Description:Recombinant human tissue kallikrein (KLK1) was obtained from R&D Systems. Pro-Phe-Arg-AMC (I-1295) substrate was obtained from Bachem. KLK1 enzyme is...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent

TargetPlasma kallikrein(Human)
Verseon

US Patent
LigandPNGBDBM162367(US9687479, 4 3-(5-[(5-chlorothiophen-2-yl)methyl]a...)
Affinity DataIC50: 5.50E+3nMpH: 7.4 T: 2°CAssay Description:Human KLKB1 protein was obtained from Enzyme Research Labs. The chromogenic substrate S-2302 was obtained from DiaPharma. KLKB1 was assayed in buffer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
Go to US Patent